Abstract: An all-solid-state battery having an increased lifespan is equipped with a pressure pad layer. More particularly, the all-solid-state battery includes a unit cell and a pressuring pad layer. The unit cell is composed of a cathode, an anode, and a solid electrolyte layer positioned between the cathode and the anode. The pressurizing pad layer is positioned on each side of the unit cell and includes a non-porous upper layer, a non-porous lower layer, and a porous core layer positioned between the non-porous upper layer and the non-porous lower layer.

Abstract: The present invention relates to a composition for preventing or treating a bone disease, obesity or an obesity-mediated metabolic disease, cancer, or cancer metastasis, and a method of screening a drug for treating the diseases, which includes an inhibitor of transmembrane 4 L six family member 19 (TM4SF19) expression or activity.

Abstract: Provided is a display device including a display panel, an optical sensor, a timing controller, a scan driver, a data driver, and an image controller. The timing controller controls an image refresh rate of the display panel based on a refresh rate control signal. Thus, the display device provides improved visibility.

Abstract: The present disclosure relates to an isolated anti-FcRN antibody, which is an antibody binding to FcRN (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmunre diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.

Abstract: Disclosed herein relates to an electrode for a lithium secondary battery and a manufacturing method thereof, and since the electrode for a lithium secondary battery is provided with an auxiliary coating layer containing inorganic particles, a phenolic compound, and a binder at the end of an electrode mixture layer containing an electrode active material, thereby improving energy density of the battery due to an improvement in thickness deviation at the end of the electrode mixture layer, and preventing lithium from being precipitated at the end of the electrode, especially the negative electrode, due to increase in the adhesive strength of the separator at the end of the electrode, it has an advantage of excellent safety.

Abstract: The present invention relates to a pidolate salt and malate salt of a compound represented by a formula 1 with an excellent liquid-phase stability, solid-phase stability, water solubility, precipitation stability and hygroscopicity all together as a compound for preventing and treating diseases mediated by an acid pump antagonistic activity, as well as a method for preparing the same.

Abstract: An all-solid-state battery system is disclosed, the system comprising an all-solid-state battery comprising a plurality of cells arranged in a closed inner space of a pressurization chamber and a pressurizing fluid filled in the closed inner space of the pressurization chamber, a state detector configured to detect state information of the all-solid-state battery, a controller configured to output a control signal configured for controlling a pressure applied to the plurality of cells by the pressurizing fluid in the inner space of the pressurization chamber based on the state information of the all-solid-state battery detected by the state detector, and a pressurizing device configured to control the pressure applied to the plurality of cells by the pressurizing fluid according to the control signal outputted by the controller.

Abstract: An all-solid-state battery, in which a cathode part and an anode part are coupled in a state of being folded in a zigzag form, is disclosed. The cathode part has a shape folded in a zigzag form such that the cathode part is divided into unit areas each corresponding to an area of a unit cathode. The anode part has a shape folded in a zigzag form such that the anode part is divided into unit areas each corresponding to an area of a unit anode. A protrusion portion of the cathode part may be inserted into a recessed portion of the anode part, and a protrusion portion of the anode part may be inserted into a recessed portion of the cathode part.

Abstract: The present disclosure relates to an isolated anti-FcRN antibody, which is an antibody binding to FcRN (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmune diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.

Abstract: The present disclosure relates to a pouch-type all-solid-state battery with a reference electrode inserted and a method for manufacturing the same. The pouch-type all-solid-state battery with a reference electrode inserted includes a unit cell including a negative electrode portion, a positive electrode portion, and a solid electrolyte portion interposed between the negative electrode portion and the positive electrode portion and having a sheet shape; an exterior material provided with a space capable of accommodating the unit cell therein; a reference electrode tap adjacent to the solid electrolyte portion, and formed inside the exterior material; and a reference electrode portion positioned between the solid electrolyte portion and the reference electrode tap, and formed inside the unit cell.

Abstract: The present disclosure provides a PUF circuit including a first array including at least one physically unclonable function (PUF) cell, a second array including at least one PUF cell, and a controller which selects a first PUF cell from the first array and selects a second PUF cell from the second array and generates unique information represented by the first PUF cell and the second PUF cell based on a first output voltage output by the first PUF cell and a second output voltage output by the second PUF cell.

Abstract: The present disclosure relates to an isolated anti-FcRn antibody, which is an antibody binding to FcRn (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmune diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.

Abstract: A pouch-type all-solid-state battery having a reference electrode and a method of manufacturing the same, includes: a unit cell including an anode portion, a cathode portion, and a solid electrolyte portion having a sheet shape and located between the anode portion and the cathode portion; and an external member including a space for accommodating the unit cell therein, wherein the solid electrolyte portion includes: an electrode accommodating portion in which the anode portion and the cathode portion are accommodated; and an extension portion having a predetermined area extending from a side surface of the electrode accommodating portion, wherein a reference electrode portion is positioned on one surface of the extension portion.

Abstract: Provided is a method of preparing a silicon composite. The method of preparing a silicon composite includes forming a silicon solution by wet-grinding a silicon raw material; forming silicon fine powder by spray-drying the silicon solution; disintegrating the silicon fine powder; forming a dispersion by coating the silicon fine powder with a first pitch; forming a first composite by coating the dispersion with a second pitch; forming a second composite by carbonizing the first composite; and classifying the second composite according to a preset particle size reference.

Abstract: The present disclosure provides a PUF circuit including a first array including at least one physically unclonable function (PUF) cell, a second array including at least one PUF cell, and a controller which selects a first PUF cell from the first array and selects a second PUF cell from the second array and generates unique information represented by the first PUF cell and the second PUF cell based on a first output voltage output by the first PUF cell and a second output voltage output by the second PUF cell.

Abstract: A fusion protein comprising factor VII (FVII) and transferrin according to the present invention has an improved specific activity of FVII compared to existing FVII fusion proteins comprising other fusion partners than transferrin, and thus can be effectively used in a therapy using FVII.

Abstract: The present disclosure relates to an isolated anti-FcRn antibody, which is an antibody binding to FcRn (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmune diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.

Abstract: The present disclosure relates to an isolated anti-FcRn antibody, which is an antibody binding to FcRn (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmune diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.

Abstract: The present disclosure relates to an isolated anti-FcRn antibody, which is an antibody binding to FcRn (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmune diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.